Currently, there are 3.02B common shares owned by the public and among those 2.04B shares have been available to trade.
The company’s stock has a 5-day price change of -6.36% and 15.24% over the past three months. STLA shares are trading 5.40% year to date (YTD), with the 12-month market performance up to 38.79% higher. It has a 12-month low price of $15.07 and touched a high of $29.51 over the same period. STLA has an average intraday trading volume of 5.61 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -9.64%, -8.48%, and 12.68% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Stellantis N.V (NYSE: STLA) shares accounts for 30.35% of the company’s 3.02B shares outstanding.
It has a market capitalization of $70.64B and a beta (3y monthly) value of 1.61. The stock’s trailing 12-month PE ratio is 3.84, while the earnings-per-share (ttm) stands at $6.40. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.57% over the week and 1.61% over the month.
Analysts forecast that Stellantis N.V (STLA) will achieve an EPS of $Stellantis N.V. for the current quarter, $24.58 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Steel Dynamics, Inc. while analysts give the company a high EPS estimate of $Intellia Therapeutics, Inc.. Comparatively, EPS for the current quarter was $STAAR Surgical Company a year ago. Earnings per share for the fiscal year are expected to decrease by -13.20%, and 1.24% over the next financial year. EPS should shrink at an annualized rate of -6.45% over the next five years, compared to 18.67% over the past 5-year period.
Piper Sandler coverage for the Stellantis N.V (STLA) stock in a research note released on March 15, 2024 offered a Overweight rating with a price target of $39. Wolfe Research on their part issued Outperform rating on February 01, 2024.
